Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 44

    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    Medical Dialogues Bureau2 Jan 2020 2:48 PM IST
    New Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
    MorphoSys seeks USFDA nod for antibody Tafasitamab to treat lymphoma

    MorphoSys seeks USFDA nod for antibody Tafasitamab to treat lymphoma

    Medical Dialogues Bureau2 Jan 2020 12:14 PM IST
    New Delhi: MorphoSys AG announced recently that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA)...
    Walvax Biotechnology offers alternative to pneumonia drug Prevnar 13 in China

    Walvax Biotechnology offers alternative to pneumonia drug Prevnar 13 in China

    Medical Dialogues Bureau2 Jan 2020 9:20 AM IST
    Pfizer's Prevnar 13, which was approved in China in 2016, was the only pneumococcal 13-valent conjugate vaccine available around the world before...
    China rolls out drug extracted from brown algae to treat Alzheimers disease

    China rolls out drug extracted from brown algae to treat Alzheimers disease

    Medical Dialogues Bureau2 Jan 2020 9:15 AM IST
    Extracted from brown algae, the medicine is said to be the world’s first innovative therapy for the treatment of Alzheimer’s disease in 17 years,...
    NPPA fixes retail price of 7 drug formulations; Details

    NPPA fixes retail price of 7 drug formulations; Details

    Farhat Nasim1 Jan 2020 10:30 AM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Alkem Labs to acquire Dronabinol assets for Rs 71 crore from AbbVie

    Alkem Labs to acquire Dronabinol assets for Rs 71 crore from AbbVie

    Farhat Nasim1 Jan 2020 10:09 AM IST
    The assets related to Dronabinol include domain names and trademarks pertaining to 'Marinol', New Drug Application (NDA) registration with US Food and...
    Indoco Remedies Febuxostat Tablets get USFDA nod to treat gout by Hyperuricemia

    Indoco Remedies Febuxostat Tablets get USFDA nod to treat gout by Hyperuricemia

    Farhat Nasim1 Jan 2020 9:45 AM IST
    Mumbai: Drugmaker, Indoco Remedies informed that the company has received final approval of its ANDA for Febuxostat Tablets 40 mg and 80 mg for the...
    Sanofi, Pfizer, GSK to hike US prices on over 200 drugs: Report

    Sanofi, Pfizer, GSK to hike US prices on over 200 drugs: Report

    Farhat Nasim1 Jan 2020 9:36 AM IST
    Nearly all of the price increases will be below 10%, and around half of them are in the range of 4 to 6%, said 3 Axis co-founder Eric Pachman. The...
    Eli Lilly gets favourable US court ruling in Alimta vitamin regimen patent lawsuit

    Eli Lilly gets favourable US court ruling in Alimta vitamin regimen patent lawsuit

    Farhat Nasim1 Jan 2020 9:35 AM IST
    "We are pleased with today's District Court ruling finding the Alimta vitamin regimen patent would be infringed by the competitor's proposed...
    Janssen Pharma completes acquisition of bermekimab from XBiotech for USD 750 million

    Janssen Pharma completes acquisition of bermekimab from XBiotech for USD 750 million

    Farhat Nasim1 Jan 2020 9:30 AM IST
    New Delhi: The Janssen Pharmaceutical Companies of Johnson & Johnson announced recently the completion of the acquisition of all rights to the...
    Similarity of Trademarks: Delhi HC refrains manufacture, sale of Rifaget, Zoe-Fer against Sun Pharma trademark Rifagut, Zofer

    Similarity of Trademarks: Delhi HC refrains manufacture, sale of Rifaget, Zoe-Fer against Sun Pharma trademark Rifagut, Zofer

    Farhat Nasim31 Dec 2019 4:51 PM IST
    New Delhi: The Delhi High Court has ordered a permanent injunction stopping the sale of drug/supplement for iron deficiency in lactating and expecting...
    Panacea Biotec hexavalent EasySix vaccine to cater to USD 1 billion market

    Panacea Biotec hexavalent EasySix vaccine to cater to USD 1 billion market

    Medical Dialogues Bureau31 Dec 2019 12:29 PM IST
    Panacea Biotec’s hexavalent vaccine, which can immunize patients against six diseases, including diphtheria, tetanus, hepatitis B and polio, will also...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Aurobindo Pharma faces CA Suit in US for concealing facts

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok